PDS Biotechnology Statistics

Total Valuation

PDSB has a market cap or net worth of $57.20 million. The enterprise value is $38.93 million.

Market Cap	57.20M
Enterprise Value	38.93M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

PDSB has 45.40 million shares outstanding. The number of shares has increased by 17.77% in one year.

Current Share Class	45.40M
Shares Outstanding	45.40M
Shares Change (YoY)	+17.77%
Shares Change (QoQ)	+1.85%
Owned by Insiders (%)	3.12%
Owned by Institutions (%)	9.97%
Float	43.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.64
P/TBV Ratio	3.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.64, with a Debt / Equity ratio of 1.15.

Current Ratio	2.64
Quick Ratio	2.44
Debt / Equity	1.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.77

Financial Efficiency

Return on equity (ROE) is -166.65% and return on invested capital (ROIC) is -49.99%.

Return on Equity (ROE)	-166.65%
Return on Assets (ROA)	-43.34%
Return on Invested Capital (ROIC)	-49.99%
Return on Capital Employed (ROCE)	-128.47%
Revenue Per Employee	n/a
Profits Per Employee	-$1.57M
Employee Count	24
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-869,169
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.23% in the last 52 weeks. The beta is 1.49, so PDSB's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	-61.23%
50-Day Moving Average	1.24
200-Day Moving Average	2.35
Relative Strength Index (RSI)	55.58
Average Volume (20 Days)	275,926

Short Selling Information

The latest short interest is 3.14 million, so 6.93% of the outstanding shares have been sold short.

Short Interest	3.14M
Short Previous Month	3.86M
Short % of Shares Out	6.93%
Short % of Float	7.15%
Short Ratio (days to cover)	4.07

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-36.32M
Pretax Income	-45.29M
Net Income	-37.61M
EBITDA	-36.26M
EBIT	-36.32M
Earnings Per Share (EPS)	-$1.03

Full Income Statement

Balance Sheet

The company has $41.69 million in cash and $21.83 million in debt, giving a net cash position of $19.86 million or $0.44 per share.

Cash & Cash Equivalents	41.69M
Total Debt	21.83M
Net Cash	19.86M
Net Cash Per Share	$0.44
Equity (Book Value)	19.00M
Book Value Per Share	0.50
Working Capital	27.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.03 million and capital expenditures -$29,000, giving a free cash flow of -$35.06 million.

Operating Cash Flow	-35.03M
Capital Expenditures	-29,000
Free Cash Flow	-35.06M
FCF Per Share	-$0.77

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PDSB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.77%
Shareholder Yield	-17.77%
Earnings Yield	-63.98%
FCF Yield	-59.64%

Analyst Forecast

The average price target for PDSB is $10.00, which is 693.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	693.65%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 18, 2019. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Mar 18, 2019
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2